London, United Kingdom

Ucl Biomedica Plc

Calculating rank
USPTO Granted Patents = 7

% Expired Patents = 71.4


Forward Citations = 111

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Mark Lowdell (2 out of 2 patents)

silverMedal Graham McIntyre (2 out of 6 patents)

bronzeMedal Oscar Adelmo Bottasso (2 out of 6 patents)

4.  John Lawson Stanford (2 out of 16 patents)

5.  Cynthia Ann Stanford (2 out of 6 patents)

6.  Helen Claire Hailes (1 out of 4 patents)

7.  Alethea Bernice Tabor (1 out of 3 patents)

8.  Stephen Lewis Hart (1 out of 10 patents)

9.  Alexander M Seifalian (1 out of 7 patents)

10.  Christopher Hurley (1 out of 28 patents)

11.  John Bosco Wong (1 out of 2 patents)

12.  Christopher Paul Swain (1 out of 20 patents)

13.  Charles Alexander Mosse (1 out of 10 patents)

14.  Henryk Salacinski (1 out of 1 patent)

15.  Kaila Srai (1 out of 1 patent)


7 patents:

Company Overview
Ucl Biomedica Plc is a leading biotechnology company specializing in the development of innovative therapies for various diseases. With a diverse portfolio of products in various stages of development, Ucl Biomedica Plc is committed to improving patient outcomes and advancing medical science. The company's team of experienced researchers and scientists are dedicated to creating cutting-edge treatments that address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

7 Patents

#435 in London

#2,345 in United Kingdom

London, GB
London, United Kingdom
Forward Citations = 111

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ucl Biomedica Plc. Retrieved from https://idiyas.com/company/ucl-biomedica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…